12:00 AM
Nov 01, 2010
 |  BC Week In Review  |  Company News  |  Deals

NeuroVive, to-BBB deal

The companies will formulate drugs to treat stroke and other acute neurodegenerative diseases by combining NeuroVive's cyclosporine-based pharmaceuticals with...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >